tiprankstipranks
CNS Pharmaceuticals (CNSP)
NASDAQ:CNSP
US Market

CNS Pharmaceuticals (CNSP) Income Statement

Compare
1,058 Followers

CNS Pharmaceuticals Income Statement

Last quarter (Q3 2024), CNS Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, CNS Pharmaceuticals's net income was $-5.61M. See CNS Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -4.13K$ -11.76K$ -13.07K$ -11.10K-
Operating Expenses
$ 18.87M$ 15.27M$ 14.03M$ 9.45M$ 3.83M
Depreciation and Amortization
$ 4.13K$ 11.76K$ 13.07K$ 11.10K-
EBITDA
$ -18.86M$ -15.26M$ -14.47M$ -9.44M$ -3.83M
Operating Income
$ -18.87M$ -15.27M$ -14.03M$ -9.45M$ -3.83M
Other Income/Expenses
$ 13.88K$ -7.03K$ -9.29K$ -3.26K$ -44.23K
Pretax Income
$ -18.85M$ -15.27M$ -14.04M$ -9.46M$ -3.88M
Net Income
$ -18.85M$ -15.27M$ -14.50M$ -9.46M$ -3.88M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -251.35$ -560.83$ -852.66$ -859.81$ -353.57
Diluted EPS
$ -250.19$ -560.83$ -825.04$ -853.68$ -353.57
Weighted Average Shares Outstanding
75.00K 27.23M 17.00M 11.00M 10.97M
Weighted Average Shares Outstanding (Diluted)
75.35K 27.23M 17.57M 11.08M 10.97M
Currency in USD

CNS Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis